51. New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses†
- Author
-
Claudiu T. Supuran, Elisabetta Bulgheroni, Ottavia Viganò, Stefania Ferramosca, Antonio Bianchi, Cecilia Cabrera, Mirko Lo Cicero, Andrea Bencini, Massimo Galli, Lidia Ruiz, Francesca Sirianni, Stefano Rusconi, and Javier Martinez-Picado
- Subjects
Chemokine ,Benzylamines ,Receptors, CXCR4 ,medicine.drug_class ,Anti-HIV Agents ,Pharmaceutical Science ,HIV Infections ,Biology ,Cyclams ,CXCR4 ,Peripheral blood mononuclear cell ,Article ,Analytical Chemistry ,lcsh:QD241-441 ,lcsh:Organic chemistry ,macrocyclic polyamines ,In vivo ,HIV Fusion Inhibitors ,Heterocyclic Compounds ,Drug Discovery ,Drug Resistance, Viral ,medicine ,Polyamines ,Humans ,Physical and Theoretical Chemistry ,Amines ,Molecular Structure ,Organic Chemistry ,Wild type ,virus diseases ,Receptor antagonist ,Virology ,In vitro ,Drug Resistance, Multiple ,Phenotype ,Viral replication ,Chemistry (miscellaneous) ,co-receptors ,biology.protein ,HIV-1 ,Molecular Medicine - Abstract
Considering as a lead molecule the chemokine CXCR4 receptor antagonist AMD-3100, which shows significant anti-HIV activity in vitro and in vivo, we investigated a series of structurally related macrocyclic polyamines incorporating o,o'-phenanthroline or 2,2'-bipyridyl scaffolds as potential antiviral agents with lower toxicity and increased activity against both wild type X4-tropic and dual tropic HIV strains. The antiviral activity of these compounds was evaluated by susceptibility assays in PBMC (Peripheral Blood Mononuclear Cells) and compared to that of AMD-3100. The newly investigated compounds showed IC(50)s values in the low micromolar range and significantly inhibited the viral replication of wild type X4-tropic isolate and dual tropic strains. These macrocyclic polyamines constitute a promising class of HIV entry inhibitors.
- Published
- 2009